HURA - TuHURA Biosciences, Inc. Company Long-Term Liabilities

Public company logo of tuhurabio.com (HURA)

The price history on the TuHURA Biosciences, Inc. (HURA) chart demonstrates the dynamics of a company developing cellular vaccines to establish long-term patent protection and ensure a stable cash flow. Growth is driven by tests of the IFx-Hu2.0 platform and methods to combat tumor resistance, with the indicator standing at 0.00. However, early-stage trials create significant liquidity threats and a total dependence on external financing.

TuHURA Biosciences, Inc. (HURA) Company Long-Term Debt: for the period 07/04/2022 - 11/01/2026

TuHURA Biosciences (HURA) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price TuHURA Biosciences Inc.|HURA - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation TuHURA Biosciences|HURA - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share TuHURA Biosciences|HURA - Company Book Value|Market Value to Book Value tuhurabio.com|HURA - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio TuHURA Biosciences, Inc.|HURA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio TuHURA Biosciences Inc.|HURA - Company Total Debt|Debts to Book Capitalization TuHURA Biosciences|HURA - Company Long-Term Debt|Company Short-Term Loans and Borrowings TuHURA Biosciences|Immediate Liquidity tuhurabio.com
- earnings and market multiples details:
HURA - Net Income
Fundamental company valuation:HURA (TuHURA Biosciences, Inc.)
Brand item of TuHURA

Long-term debt measures the total liabilities with a maturity exceeding one year, determining the sustainability of financial leverage and the risk of default. For TuHURA Biosciences, Inc. (HURA), such funds are critical for financing costly R&D and retaining rare immunotherapy specialists. Analyzing the company's long-term debt allows for tracking borrowing rates relative to capitalization. Stable dynamics confirm balanced development without critical balance sheet overheating.

Competitors of TuHURA Biosciences, Inc. (HURA)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt UroGen Pharma Ltd.|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DCTH (Delcath)|YMAB - Company Long-Term Liabilities|AURA: Company Long-Term Liabilities|CADL - Company Long-Term Debts|Accuray (ARAY) - Company Long-Term Debt|SELLAS Life Sciences Group - Company Long-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Long-Term Debts|Long-Term Debt Citius Oncology Inc CTOR|Company Long-Term Liabilities TARA (Protara Therapeutics)|Amount of Long-Term Liabilities FATE|Aadi Bioscience - Company Long-Term Liabilities|Company Long-Term Debts TScan Therapeutics Inc TCRX|Champions Oncology Corp - Company Long-Term Debts|Company Long-Term Loans and Borrowings XBIT (XBiotech Inc.)|CVM (cel-sci.com) - Company Long-Term Liabilities|ostherapies.com (OSTX) - Company Long-Term Debts|Company Long-Term Debt Radiopharm Theranostics Limited|ARTV: Company Long-Term Loans and Borrowings|Company Long-Term Debts ANL|Company Long-Term Debts Veru Corporation (VERU)|Tempest Therapeutics - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings XLO|Enochian BioSciences - Company Long-Term Debts|MURA: Company Long-Term Debt|KAPA: Company Long-Term Debts|OKUR - Long-Term Debt Volume|Company Long-Term Debt CytoMed Therapeutics Ltd|Long-Term Debt Curis Corp CRIS|Company Long-Term Debt Apollomics, Inc. (APLM)|Long-Term Debt Volume Tharimmune Inc|Company Long-Term Debts ADVB (Advanced Biomed)|GNPX - Company Long-Term Liabilities|Calidi Bio - Company Long-Term Debts|Long-Term Debt Volume Sunshine Biopharma Inc. SBFM|XBIO: Company Long-Term Debts|Long-Term Debt Salarius Pharmaceuticals Inc (SLRX)|Company Long-Term Debt Purple Biotech Corp|Company Long-Term Indebtedness AONC (AON)|Company Long-Term Debts BGNE|Company Long-Term Liabilities checkpointtx.com CKPT|Company Long-Term Debts ELEV (Elevation Oncology, Inc.)|iCAD Inc. (ICAD) - Long-Term Debt|IKNA - Company Long-Term Debt|Long-Term Debt Volume Notable Labs Corp NTBL|VIRX (viracta.com) - Company Long-Term Liabilities|morphosys.com - Company Long-Term Loans and Borrowings|NAYA (NAYA Biosciences Inc.) - Company Long-Term Debts|Ascentage Pharma Group International (AAPGV) - Long-Term Debt Volume